Egfrmutant stage IIIB/C or IV non-squamous NSCLC

Clinical trials for Egfrmutant stage IIIB/C or IV non-squamous NSCLC explained in plain language.

Never miss a new study

Get alerted when new Egfrmutant stage IIIB/C or IV non-squamous NSCLC trials appear

Sign up with your email to follow new studies for Egfrmutant stage IIIB/C or IV non-squamous NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New combo therapy shows promise for hard-to-treat lung cancer

Disease control Completed

This study tested a new drug combination for people with a specific type of advanced lung cancer (EGFR-mutant non-small cell) that had stopped responding to standard targeted pills. The trial enrolled 95 adults and gave them two different combinations of immunotherapy (atezolizum…

Matched conditions: EGFRMUTANT STAGE IIIB/C OR IV NON-SQUAMOUS NSCLC

Phase 2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control

Last updated Jul 31, 2026 00:00 UTC

Egfrmutant stage IIIB/C or IV non-squamous NSCLC

Get alerted when new Egfrmutant stage IIIB/C or IV non-squamous NSCLC trials appear

New combo therapy shows promise for hard-to-treat lung cancer